Tuesday’s market has seen swings in various stocks based on news and other factors. Today, stocks like Micron Technology and Lam Research are rallying, while stocks like Applovin and Tesla Motors are ...

Alloy Therapeutics has appointed Christian Cobaugh, Ph.D., as Chief Executive Officer of Alloy Genetic Medicines.

Cathie Wood is making a massive bet on gene editing, pouring $5.4 billion into companies like Beam Therapeutics while selling ...

Alloy Therapeutics today announced the appointment of Christian Cobaugh, Ph.D., as Chief Executive Officer of Alloy Genetic ...

Tiny, sun-powered organisms found in freshwater pools could soon fuel Hawaiʻi’s sustainable future, according to researchers ...

In a first for the UAE, the Yas Clinic in Khalifa City, working with the Abu Dhabi Stem Cells Centre and Vertex ...

Looking back at the performance of ARK Invest, led by Cathie Wood (“Cathie Wood”), in 2025, despite reducing its holdings of Tesla (TSLA) by over 633,000 shares during the ...

In the latest close session, CRISPR Therapeutics AG (CRSP) was up +2.58% at $55.16. This change outpaced the S&P 500's 0.64% gain on the day. Elsewhere, the Dow saw an upswing of 1.23%, while the tech ...

Since 2019, three disease-specific therapies have been approved to treat patients with ATTR-CM. The first was Pfizer’s Vyndamax (tafamidis) in May 2019, which was approved for both wild type and ...

Tiny, sun-powered organisms found in freshwater pools could soon fuel Hawaiʻi's sustainable future. Researchers at the ...

The US Food and Drug Administration (FDA) has cleared GenEditBio Limited’s Investigational New Drug (IND) application to ...

CHANGE-seq-BE was developed to enable scientists to better understand base editors, an important class of CRISPR precise genome editors.